Last edition
News about "cholesterol management "
Zydus Secures Final Approval from USFDA for Niacin Extended-Release Tablets
Zydus Lifesciences has received final USFDA approval to manufacture Niacin Extended-Release Tablets in 500 mg, 750 mg, and 1,000 mg dosage, targeting cholesterol management and cardiovascular risk reduction.
Cholesterol Management | 30/04/2025 | By Abha | 269
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members